Effect of a novel FAK inhibitor targeted to the binding site of VEGFR3 on pancreatic cancer proliferation in vitro and in vivo.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. V. Kurenova, J. Liao, D. He, D. L. Hunt, A. Chekhau, S. N. Hochwald, D. A. Ostrov, W. G. Cance
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2588869480
